SCENESSE
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for SCENESSE, covering 2009-09-15 to 2026-01-30. Get the full timeline:
Most recent: EMA Authorised: Scenesse (afamelanotide) — Clinuvel Europe Limited
7 regulatory and trial events tracked for SCENESSE, covering 2009-09-15 to 2026-01-30. Get the full timeline:
Most recent: EMA Authorised: Scenesse (afamelanotide) — Clinuvel Europe Limited